What is Shijiazhuang Yiling Pharmaceutical Co Revenue per Share?
Shijiazhuang Yiling Pharmaceutical Co's revenue per share for the
three
months ended in Mar. 2024 was ¥1.51.
Shijiazhuang Yiling Pharmaceutical Co's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5.33.
Warning Sign:
Shijiazhuang Yiling Pharmaceutical Co Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Shijiazhuang Yiling Pharmaceutical Co was -35.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 5.50% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 19.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 17.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
SZSE:002603'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.4 Med: 13 Max: 29.4
Current: 5.5
During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest 3-Year average Revenue Per Share Growth Rate was 29.40% per year. The lowest was -7.40% per year. And the median was 13.00% per year.
SZSE:002603's 3-Year Revenue Growth Rate is ranked worse than 53.15% of 922
companies
in the Drug Manufacturers industry
Industry Median: 6.4
vs SZSE:002603: 5.50
Shijiazhuang Yiling Pharmaceutical Co Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shijiazhuang Yiling Pharmaceutical Co Revenue per Share Chart
Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's Revenue per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shijiazhuang Yiling Pharmaceutical Co's PS Ratio Distribution in the Drug Manufacturers Industry
* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's PS Ratio falls into.
Shijiazhuang Yiling Pharmaceutical Co Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5.33
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Shijiazhuang Yiling Pharmaceutical Co Revenue per Share Related Terms
Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002603 has been successfully added to your 